key: cord-0970982-xjgo8vdt authors: Kates, Olivia S; Diekema, Douglas S; Blumberg, Emily A title: Should healthcare institutions mandate SARS-CoV-2 vaccination for staff? date: 2021-04-02 journal: Open Forum Infect Dis DOI: 10.1093/ofid/ofab155 sha: 070e54f88e1ff2cd82f03b2fbee6b45e684b4bef doc_id: 970982 cord_uid: xjgo8vdt Healthcare workers have been prioritized for SARS-CoV-2 vaccination, but vaccine hesitancy among workers may limit uptake. Institutions may wish to consider SARS-CoV-2 vaccine mandates for healthcare workers, but such proposals raise important ethical questions. Arguments supporting mandates emphasize the proposed favorable balance of harms and benefits for both individuals and communities, as well as moral duties of healthcare workers and organizations. Arguments in opposition seek to challenge some claims about utility and raise additional concerns about infringement on autonomy, damage to organizational relationships, and injustice. While available SARS-CoV-2 vaccines remain under an experimental designation, mandates may be excessively problematic, but following approval by the Food and Drug Administration mandates may be reconsidered. The authors summarize ethical arguments and practical considerations, concluding that mandates may be ethically permissible in select circumstances. The emergency use authorization by the FDA of three highly effective vaccines against SARS-CoV-2 has been a source of hope in a protracted pandemic. Healthcare workers have been prioritized for vaccination for multiple reasons: to protect a population likely to encounter patients with COVID-19, to prevent transmission to patients, to preserve healthcare capacity, and to facilitate vaccine distribution. But healthcare workers are not immune to vaccine hesitancy. Uptake of the SARS-CoV-2 vaccine has been uneven, with reported acceptance rates ranging from less than 50% to nearly 100% in different institutions. 1 Reasons for hesitancy include the novelty of the vaccine and the mRNAbased mechanism, the accelerated development and authorization process, reports of side effects, perceived low risk of transmission, and even skepticism about the seriousness of COVID-19 illness. These concerns may be in addition to broader skepticism about the trustworthiness, safety, and utility of vaccination in general. 2 Confronted with high rates of vaccine refusal, some centers have considered mandating SARS-CoV-2 vaccination among workers with direct patient contact. While available vaccines remain under an emergency use authorization, mandates have been called "legally and ethically problematic" because vaccines are still considered experimental. 3 However, emerging challenges in vaccination of healthcare workers should prompt planning for future approval of SARS-CoV-2 vaccines. We consider ethical arguments for and against vaccine mandates, addressing domains of utility, duties, autonomy, care, and justice. Widespread vaccination of healthcare workers achieved through mandates could be expected to have a favorable balance of benefits and harms, in alignment with the ethical principles of beneficence and non-maleficence. Healthcare workers have been prioritized for SARS-CoV-2 vaccination because of the individual and community benefits anticipated from protecting this A c c e p t e d M a n u s c r i p t group. If voluntary uptake remains low, these benefits would be attenuated. Mandatory vaccination could help to ensure the safety of a larger group of healthcare workers. Arguments in favor of mandates generally assume that vaccination will also reduce transmission, so that these benefits would be extended to include patients and visitors. Beyond the healthcare setting, successful vaccination of healthcare workers sets a valuable example for the public and enhances the credibility of public calls for vaccine acceptance. Vaccination against SARS-CoV-2 is not onerous and reasonably thought to be safe, so healthcare workers could be considered to have an ethical duty to take this step to protect patients as a kind of "easy rescue," a moral requirement to act when a low-burden action can save others from a much worse situation. Healthcare institutions also have a duty to provide a safe environment for their workforce, patients, and visitors, a duty that has been reiterated throughout the COVID-19 pandemic in discussions about personal protective equipment shortages. There is an established precedent for this proposal in influenza vaccine mandates for healthcare workers, which are considered justified intrusions on autonomy because of individual and community benefits. These benefits are even more urgently needed for the more prevalent, costly, and lethal SARS-CoV-2, which public messaging has repeatedly reminded us "is not the flu." Mandating vaccination would be an infringement on healthcare workers' autonomy. Where such infringements are permitted, they are based on a long, established track record of benefit and safety, as for influenza vaccination. In contrast, SARS-CoV-2 vaccines remain under an experimental designation, and some proposed benefits are uncertain. The role of vaccination in reducing disease transmission has yet to be demonstrated in high-quality studies and thus is a weak justification for mandates. Evidence also supports highly effective alternative strategies for interrupting transmission, including universal masking, prevalence testing, and cohorting of COVID-19 patients. 4 A SARS-CoV-2 vaccine mandate may also lead to harms not seen with mandates for influenza A c c e p t e d M a n u s c r i p t vaccination. If the consequences of a mandate lead to re-deployment of staff who refuse vaccines, there may be shortages in critical areas, negating the proposed benefit of preserving a functioning healthcare system. Even as more data become available, SARS-CoV-2 vaccine mandates are likely to be controversial. Healthcare workers' enthusiasm for vaccination has been leveraged to promote vaccine acceptance in other populations. Authoritarian-appearing vaccine mandates could undermine this discourse and have a negative effect on uptake. Mandates would also place vaccine hesitant healthcare workers explicitly in conflict with their institutions and leaders, adding to accumulated adverse experiences from a protracted pandemic and reinforcing any feelings of isolation, mistrust, or betrayal within these relationships. If those who refuse vaccination are excluded from certain types of work such as providing intensive care or subject to 14-day quarantines with high-risk exposures, there may also be economic consequences, which deserve special consideration in a time when many families face challenges from loss of income. Finally, vaccine deliberation is more common among people of color as a consequence of untrustworthy actions by healthcare professionals and organizations through history to the present day. 5 Healthcare workers from minoritized backgrounds may be disproportionately affected by both the emotional and practical consequences of a SARS-CoV-2 vaccine mandate, raising concerns about justice. Vaccine mandates may impose a spectrum of consequences, from simple opt-out options to mandatory counseling to redeployment, with differing ethical implications. One previously used proportional consequence for healthcare workers declining influenza vaccination -wearing a mask to work -is currently not relevant in the context of universal masking, but as restrictions relax institutions will need to consider how unvaccinated employees will safely participate in in-person meetings, congregate mealtimes, or other gatherings. To reduce the need to impose negative A c c e p t e d M a n u s c r i p t consequences, interventions to promote vaccine acceptance should be a part of any vaccination program, and can be implemented immediately. These might include targeted education, peer champions, or modest incentives like coffee and food. More substantial incentives may raise similar ethical questions to mandates, but have also been proposed. Some organizations may wish to consider mandates specifically for staff working with vulnerable patients. Immunosuppressed patients such as solid organ transplant recipients, bone marrow transplant recipients, or patients with cancer are frequently cohorted together and cared for by specialized teams. These patients are at higher risk for acquiring infection and go on to experience high rates of morbidity and mortality from COVID-19. 6 Arguments emphasizing benefits for or duties to patients would be magnified in this context, and implementation may be more practical for these groups than for other vulnerable groups who are not cohorted together, such as elderly patients or patients of color. Still, alternative infection prevention strategies may be sufficient to protect vulnerable patients. SARS-CoV-2 vaccine mandates for healthcare workers have the potential to secure important benefits for the individuals who are vaccinated and for the community, but at the expense of controversy, conflict, and infringement on autonomy. These costs can be expected to disproportionately affect minoritized healthcare workers unless comprehensive parallel interventions can earn broad vaccine acceptance. While vaccines are under emergency use authorization, we agree with other authors that there is insufficient evidence or certainty of benefit to justify such costs. If a vaccine earns regulatory approval with a favorable profile of individual risks and benefits, and if it proves to reduce transmission to others, then vaccine mandates for healthcare Vaccine rollout hits snag as health workers balk at shots. AP News Unpacking Vaccine Hesitancy Among Healthcare Providers Mandating COVID-19 Vaccines Hospital affiliated long term care facility COVID-19 containment strategy by using prevalence testing and infection control best practices Exploring the Continuum of Vaccine Hesitancy Between African American and White Adults: Results of a Qualitative Study COVID-19 in Immunocompromised Hosts: What We Know So Far M a n u s c r i p t workers may be reconsidered. It is the opinion of the authors that mandates would be ethically appropriate if and when these conditions are met, which is anticipated for many candidate SARS-CoV-2 vaccines, at least for those working with select high risk patient populations. Institutions should prepare to address or mitigate ethical challenges by developing informational resources, soliciting diverse staff participation in policy development, and identifying proportional incentives and consequences.A c c e p t e d M a n u s c r i p t The authors report no conflicts of interest related to the content of the manuscript, and no funding source for this work. No patients were involved in this work.A c c e p t e d M a n u s c r i p t